• SIGN IN
  • GET HELP
  •  

    Home Study Details


    Program Type

    Home Study Webcast

    Credits

    1.25 Contact Hour(s)

    Release Date

    Wednesday, July 15, 2020

    Offline Date

    Friday, July 15, 2022

    ACPE Expiration Date

    Sunday, January 15, 2023

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $4.00

    • Overview

      Fentanyl is 75-100 times more potent than oral morphine, leading transdermal fentanyl to be one of the most potent opioids. Recently, inappropriate prescribing patterns of transdermal fentanyl has drastically increased, potentially causing life threatening errors. This presentation uses a particular dangerous case study to discuss the current trends of these inappropriate prescribing patterns. These trends include prescribing to opiate naïve patients, incorrectly utilizing transdermal fentanyl in patients unable to take oral medications, and patients incorrectly labeled with codeine allergies. This presentation covers the necessary information to educate anyone on the appropriate criteria for prescribing transdermal fentanyl and will provide case-based scenarios to guide healthcare providers to manage inappropriate prescriptions.  

      Handouts

      • Slide Document :   19219H01_2pp.pdf
      • Slide Document :   19219H01_6pp.pdf

      Financial Support By

      PharmCon
    • Pharmacist

      List the cytochrome P450 3A4 inhibitors that interact with transdermal fentanyl.
      Identify which immediate release fentanyl products are registered under the FDA REMS program.
      List the 8 clinical pearls of prescribing transdermal fentanyl.
      List the 4 FDA recommendations and considerations for prescribing transdermal fentanyl released in the 2007 Health Care Advisory.
      Determine the correct treatment recommendations for transdermal fentanyl overdoses.
      Identify the risks associated with utilizing transdermal fentanyl.
      Identify the recommended requirements for initiation or conversion to transdermal fentanyl.

      Pharmacy Technician

      Identify which immediate release fentanyl products are registered under the FDA REMS program.
      Identify the risks associated with utilizing transdermal fentanyl.
      List the 4 FDA recommendations and considerations for prescribing transdermal fentanyl released in the 2007 Health Care Advisory.
      List the 8 clinical pearls of prescribing transdermal fentanyl.
      Identify the recommended requirements for initiation or conversion to transdermal fentanyl.
      Define the relative potency of transdermal fentanyl compared to oral morphine.

      Nurse

      Identify the recommended requirements for initiation or conversion to transdermal fentanyl.
      Determine the correct treatment recommendations for transdermal fentanyl overdoses.
      Identify the risks associated with utilizing transdermal fentanyl.
      Identify which immediate release fentanyl products are registered under the FDA REMS program.
      List the 4 FDA recommendations and considerations for prescribing transdermal fentanyl released in the 2007 Health Care Advisory.
      List the 8 clinical pearls of prescribing transdermal fentanyl.
      List the cytochrome P450 3A4 inhibitors that interact with transdermal fentanyl.
    • Activity Type

      Knowledge

      CE Broker

      20-784140

      Universal Activity Number

      Pharmacist 0798-0000-19-219-H01-P
      Pharmacy Technician 0798-0000-19-219-H01-T
      Nurse 0798-0000-19-219-H01-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, participants must score no less than a 70% on the activity's test and complete a program evaluation.


    HARDWARE REQUIREMENTS
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
    Speakers or headphones
     


    SOFTWARE REQUIREMENTS
    Microsoft Edge
    Internet Explorer 8.0 or higher
    Google Chrome
    Safari
    Firefox 3.0.3 or higher


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).